The FDA has accepted a new drug application for aficamten, a new obstructive hypertrophic cardiomyopathy drug. A goal date ...
Upadacitinib was superior to dupilumab for the treatment of atopic dermatitis in the head and neck, trunk, upper limbs, and lower limbs.
A recent study presented by Orit Cohen Barak in the ACR Convergence 2024 showed that with the extra advantage of a ...
Siga's financial stability is threatened by potential policy changes, while Emergent's favorable valuation metrics position ...